Postoperative complications, in-hospital outcomes and costs after kidney cancer surgery
Friday, 18 May 2012- Postoperative complications for open radical nephrectomy (ORN), laparoscopic radical nephrectomy (LRN), and open partial nephrectomy (OPN) and its relationship with hospitalisation costs and mortality remain poorly described.
S. Kim and colleagues conducted a study a...
US research examines biomarkers for prostate cancer detection, recurrence
Thursday, 17 May 2012- Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, according to a Mayo Clinic study conducted in the US.
These...
Characteristics of bladder cancer after radiotherapy for prostate cancer
Wednesday, 16 May 2012- Prostate radiotherapy (RT) has been associated with an increased risk of bladder cancer (CaB). However it is unknown how prior RT affects the stage, grade, and histology of secondary CaB. While irradiated patients have adverse surgical outcomes, how RT affects survival is...
Simple urine test predicts AKI in sepsis patients
Tuesday, 15 May 2012- A simple and inexpensive urine test appears to predict which sepsis patients will go on to develop an acute kidney injury (AKI), researchers said here.
Patients who were found to have de novo dipstick proteinuria had a significantly higher risk of AKI (P=0.001), Dr. Javier...
Assessing the safety of extraperitoneal laparoscopic radical prostatectomy: a Chinese study
Monday, 14 May 2012- Although many midterm oncologic data have been reported for extraperitoneal laparoscopic radical prostatectomy (ELRP) in western countries, few oncologic data of the extraperitoneal procedure was published in China.
X. Li and colleagues conducted a study to evaluate the...
Biopsy-detectable prostate cancer using the Prostate Cancer Prevention Trial Risk Calculator
Friday, 11 May 2012- In a study conducted by Y. Liang and colleagues, the risks of prostate cancer (CaP) and high-grade CaP were evaluated using the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) in an age-stratified random sample of 1,021 Caucasian and African-American men with no...
Limit PSA tests to younger men to lower risks of metastatic disease, research says
Thursday, 10 May 2012- Healthy younger men should be screened regularly for prostate cancer using prostate-specific antigen (PSA) testing, but older men in poor health should not be, researchers suggested.
Healthy men ages 53 to 64 who were enrolled in a major cancer screening trial had a rate of...
Maternal UTI as a risk factor for neonatal urinary tract
Wednesday, 9 May 2012- F. Emamghorashi and colleagues conducted a study to evaluate the association of maternal UTI during pregnancy with neonatal UTI. They published their findings in the Iranian Journal of Kidney Diseases.
One hundred and fourteen neonates admitted to hospital were...
Efficacy of docetaxel-based chemotherapy following ketoconazole in mCRPC patients
Tuesday, 8 May 2012- Abiraterone acetate (AA) is a CYP17 inhibitor of androgen synthesis approved for use following docetaxel for metastatic castration-resistant prostate cancer (mCRPC); evaluation in the pre-docetaxel setting is ongoing.
Given that the reported efficacy of AA is lower following...
Severe ED linked with overactive bladder wet
Monday, 7 May 2012- Diabetes is a common risk factor for overactive bladder (OAB) syndrome and erectile dysfunction (ED).
R. Liu and colleagues conducted a study which evaluated the risk factors of OAB and association of OAB and ED in type 2 diabetic men. They published their report in the Journal...














